908 related articles for article (PubMed ID: 7732782)
1. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
2. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
Ma CG; Zhang GX; Xiao BG; Link H
Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
[TBL] [Abstract][Full Text] [Related]
3. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
[TBL] [Abstract][Full Text] [Related]
4. Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.
Navikas V; He B; Link J; Haglund M; Söderström M; Fredrikson S; Ljungdahl A ; Höjeberg J; Qiao J; Olsson T; Link H
Brain; 1996 Feb; 119 ( Pt 1)():213-23. PubMed ID: 8624683
[TBL] [Abstract][Full Text] [Related]
5. Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis.
Tian WZ; Navikas V; Matusevicius D; Söderström M; Fredrikson S; Hedlund G; Link H
Acta Neurol Scand; 1998 Aug; 98(2):94-101. PubMed ID: 9724006
[TBL] [Abstract][Full Text] [Related]
6. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
Rohowsky-Kochan C; Molinaro D; Cook SD
Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
[TBL] [Abstract][Full Text] [Related]
7. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
[TBL] [Abstract][Full Text] [Related]
8. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells.
Matusevicius D; Navikas V; Söderström M; Xiao BG; Haglund M; Fredrikson S; Link H
J Neuroimmunol; 1996 May; 66(1-2):115-23. PubMed ID: 8964905
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis.
Matusevicius D; Navikas V; Palasik W; Pirskanen R; Fredrikson S; Link H
J Neuroimmunol; 1996 Dec; 71(1-2):191-8. PubMed ID: 8982119
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.
Matusevicius D; Kivisäkk P; He B; Kostulas N; Ozenci V; Fredrikson S; Link H
Mult Scler; 1999 Apr; 5(2):101-4. PubMed ID: 10335518
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
Wang ZY; He B; Qiao J; Link H
J Neuroimmunol; 1995 Dec; 63(1):79-86. PubMed ID: 8557828
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for myasthenia gravis (MG).
Huang YM; Kivisäkk P; Ozenci V; Pirskanen R; Link H
Clin Exp Immunol; 1999 Nov; 118(2):304-8. PubMed ID: 10540195
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment.
Ozenci V; Kouwenhoven M; Huang YM; Xiao B; Kivisäkk P; Fredrikson S; Link H
Scand J Immunol; 1999 May; 49(5):554-61. PubMed ID: 10320650
[TBL] [Abstract][Full Text] [Related]
16. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
17. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
Hermans G; Stinissen P; Hauben L; Van den Berg-Loonen E; Raus J; Zhang J
Ann Neurol; 1997 Jul; 42(1):18-27. PubMed ID: 9225681
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
19. Influence of IFN-beta1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis.
Matusevicius D; Kivisakk P; Navikas V; Tian W; Soderstrom M; Fredrikson S; Link H
Eur J Neurol; 1998 May; 5(3):265-275. PubMed ID: 10210841
[TBL] [Abstract][Full Text] [Related]
20. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Fredrikson S; Kivisäkk P; Ljungdahl A; Höjeberg B; Link H
J Neuroimmunol; 1996 Jan; 64(1):63-9. PubMed ID: 8598391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
